Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Japan
100%
Treatment Efficacy
100%
Autoimmune Autonomic Ganglionopathy
100%
Autonomic Symptoms
50%
Antibody Level
50%
Treatment Strategy
33%
Symptom Score
33%
Combined Therapy
33%
Number of Symptoms
33%
Effective Treatment
16%
Cyclosporine
16%
Tacrolimus
16%
Clinical Symptoms
16%
Rating Scales
16%
Assessment Scale
16%
Plasma Exchange
16%
Gastrointestinal Diseases
16%
Intravenous Immunoglobulin (IVIg)
16%
Autoantibodies
16%
Response to Treatment
16%
Accurate Assessment
16%
Immunosuppressive Therapy
16%
Mycophenolate Mofetil
16%
Methylprednisolone
16%
Appropriate Treatment
16%
Improvement Factor
16%
Clinical Response
16%
Randomized Placebo-controlled Trial
16%
Assessment Method
16%
Ganglionic Acetylcholine Receptor
16%
Oral Steroids
16%
Combination Immunotherapy
16%
Post-treatment Changes
16%
Anti-ganglionic Acetylcholine Receptor Antibodies
16%
Orthostatic Intolerance
16%
Sicca Symptoms
16%
Immunology and Microbiology
Immunotherapy
100%
Immunology
50%
Tacrolimus
12%
Blood Plasma
12%
Intravenous Immunoglobulin
12%
Autoantibodies
12%
Ciclosporin
12%
Standing
12%
Cholinergic Receptor Antibody
12%
Methylprednisolone
12%
Mycophenolate Mofetil
12%
Neuroscience
Immunotherapy
100%
Autoantibodies
12%
Intravenous Immunoglobulin
12%
Cholinergic Receptor
12%
Placebo
12%
Methylprednisolone
12%
Ciclosporin
12%
Tacrolimus
12%
Cholinergic Receptor Antibody
12%
Blood Plasma
12%
Mycophenolate Mofetil
12%